B细胞激活因子
免疫学
免疫系统
人口
癌症研究
细胞毒性T细胞
医学
细胞因子
贝里穆马布
炎症
CD8型
抗体
肿瘤坏死因子α
自身免疫
狼疮性肾炎
细胞凋亡
先天免疫系统
生物
下调和上调
串扰
促炎细胞因子
红斑狼疮
肺
内皮干细胞
补体系统
系统性红斑狼疮
细胞生物学
单克隆抗体
免疫失调
作者
Xuehan Jiang,Leyao Ma,Yutong Li,Xiaoyue Deng,Qizhi Yuan,Junwei Zhang,Huiyuan Hu,Yidan Gao,Xingbei Dong,Yuhuan Tao,Wenjia Zhang,Junyan Qian,Yanjiang Xing,Yufei Hu,Hong Zhang,Jiuliang Zhao,Qian Wang,Xiaofeng Zeng,Yuanhua Yang,Wanlu Song
出处
期刊:Circulation Research
[Lippincott Williams & Wilkins]
日期:2026-09-24
卷期号:139 (10): e328338-e328338
被引量:1
标识
DOI:10.1161/circresaha.126.328338
摘要
BACKGROUND: Pulmonary arterial hypertension (PAH) is a fatal complication of systemic lupus erythematosus (SLE), yet the mechanisms linking autoimmune dysregulation to progressive pulmonary vascular remodeling are poorly defined, leading to inadequate therapies. This study investigated BAFF (B-cell activating factor), a key cytokine in SLE, as a potential driver of SLE-PAH pathogenesis. METHODS: BAFF expression was assessed in patients with SLE-PAH and animal models. Humanized BAFF-transgenic mice were generated to investigate the effects of BAFF elevation on serological, hemodynamic, and histological parameters of SLE and PAH. Single-cell RNA sequencing, flow cytometry, histological analyses, and cell-based experiments were performed to elucidate cellular and molecular mechanisms. The therapeutic efficacy of the BAFF-neutralizing antibody Belimumab was tested in 2 distinct SLE-PAH animal models. RESULTS: BAFF was significantly upregulated in both SLE-PAH patient cohorts and animal models. Humanized BAFF-transgenic mice exhibited systemic B-cell hyperactivation and pulmonary infiltration and spontaneously developed hallmark features of both SLE and PAH. Single-cell transcriptomic analysis of lung tissues revealed that BAFF overexpression drove the increase of a novel, disease-specific S 100a6 + mature B-cell subset, which orchestrated a pathogenic immune cascade by activating a cytotoxic Gzmk + CD8 + T-cell population via MHC-I (major histocompatibility complex class I)-mediated antigen presentation and CD80-CD28 costimulation. This B-T cell crosstalk triggered apoptosis of a susceptible endothelial cell subpopulation through Fas/Fas ligand signaling, ultimately culminating in pulmonary vascular remodeling. The BAFF-neutralizing antibody Belimumab effectively ameliorated both autoimmune and cardiopulmonary manifestations in 2 distinct SLE-PAH animal models, while improving survival. CONCLUSIONS: These findings establish BAFF as a key mediator in SLE-PAH, driving a previously unrecognized pathogenic immune axis connecting dysregulated B cells to T-cell-mediated endothelial injury. BAFF inhibition may represent a therapeutic strategy for SLE-PAH.
科研通智能强力驱动
Strongly Powered by AbleSci AI